These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 27490860)
61. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride. Booze RM; Wallace DR Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338 [TBL] [Abstract][Full Text] [Related]
62. Striatal dopamine D2/3 receptor availability in treatment resistant depression. de Kwaasteniet BP; Pinto C; Ruhé HG; van Wingen GA; Booij J; Denys D PLoS One; 2014; 9(11):e113612. PubMed ID: 25411966 [TBL] [Abstract][Full Text] [Related]
63. In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles. Assié MB; Dominguez H; Consul-Denjean N; Newman-Tancredi A Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):441-50. PubMed ID: 16947046 [TBL] [Abstract][Full Text] [Related]
64. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer. Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888 [TBL] [Abstract][Full Text] [Related]
65. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors. Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145 [TBL] [Abstract][Full Text] [Related]
66. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis. Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776 [TBL] [Abstract][Full Text] [Related]
67. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation. Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958 [TBL] [Abstract][Full Text] [Related]
68. Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1 Kondej M; Bartyzel A; Pitucha M; Wróbel TM; Silva AG; Matosiuk D; Castro M; Kaczor AA Molecules; 2018 Sep; 23(9):. PubMed ID: 30181442 [TBL] [Abstract][Full Text] [Related]
69. Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism. Salmas RE; Yurtsever M; Durdagi S J Biomol Struct Dyn; 2017 Mar; 35(4):738-754. PubMed ID: 26923489 [TBL] [Abstract][Full Text] [Related]
70. A comparison of two semi-mechanistic models for prolactin release and prediction of receptor occupancy following administration of dopamine D2 receptor antagonists in rats. Taneja A; Vermeulen A; Huntjens DRH; Danhof M; De Lange ECM; Proost JH Eur J Pharmacol; 2016 Oct; 789():202-214. PubMed ID: 27395799 [TBL] [Abstract][Full Text] [Related]
71. Dopamine/serotonin receptor ligands. Part 17: a cross-target SAR approach: affinities of azecine-styled ligands for 5-HT(2A) versus D1 and D2 receptors. Enzensperger C; Görnemann T; Pertz HH; Lehmann J Bioorg Med Chem Lett; 2008 Jul; 18(13):3809-13. PubMed ID: 18534847 [TBL] [Abstract][Full Text] [Related]
72. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains. Robinson SW; Jarvie KR; Caron MG Mol Pharmacol; 1994 Aug; 46(2):352-6. PubMed ID: 7915820 [TBL] [Abstract][Full Text] [Related]
73. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine. Kodaka F; Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Okumura M; Otsuka T; Nakayama K; Halldin C; Farde L; Suhara T Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881 [TBL] [Abstract][Full Text] [Related]
74. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles. Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766 [TBL] [Abstract][Full Text] [Related]
75. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone. Logan J; Fowler JS; Dewey SL; Volkow ND; Gatley SJ J Neural Transm (Vienna); 2001; 108(3):279-86. PubMed ID: 11341479 [TBL] [Abstract][Full Text] [Related]